Spyre Therapeutics, Inc. (SYRE) › Shares OutstandingSpyre Therapeutics, Inc. (SYRE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 757.3K2016: 13.43M2017: 16.67M2018: 24.14M2019: 29.08M2020: 47.96M2021: 49.36M2022: 2.61M2023: 36.06M2024: 60.26M2025: 78.19M78.19M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202578.19M+29.8%202460.26M+67.1%202336.06M+1279.4%20222.61M-94.7%202149.36M+2.9%202047.96M+64.9%201929.08M+20.5%201824.14M+44.8%201716.67M+24.1%201613.43M+1673.4%2015757.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share